BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medical's Board of Directors


11/20/2012 8:55:55 AM

WESTMINSTER, Colo., Nov. 20, 2012 /PRNewswire/ -- Surefire Medical, Inc., a developer of innovative high-efficiency infusion systems for the interventional radiology and interventional oncology markets, today announced the appointment of Gene McGrevin to its Board of Directors.

"Gene McGrevin is an excellent medical device strategist with a very strong background in sales, marketing and in running public companies. As Surefire Medical transitions to full-scale commercialization in the U.S., Europe and Asia, Gene's addition to the Surefire Board is both timely and a great gain for the company," said Surefire Medical Board chairman Norman Weldon.

With 25 years of senior management positions in the medical industry at companies including Johnson & Johnson and Kimberly-Clark Corporation, Mr. McGrevin also was instrumental in the expansion and sale of several medical startups. They include PetNet Pharmaceuticals (sold to Siemens), Microtek Medical Holdings (sold to EcoLabs), and Medivance (sold to C.R. Bard).

"In my judgment Surefire Medical has the three key ingredients for success in the marketplace," McGrevin said. "The company has innovative technology that physicians are quickly adopting due to its proven clinical impact on patient care. It has strong IP. And with higher embolization efficiency, Surefire Medical's infusion devices are cost-effective as well as clinically relevant."

Mr. McGrevin also serves on the Boards of the Yerkes Primate Center, Real Time Medical Data and HydroDynamics.

"We are delighted that Gene has joined the Board of Directors of Surefire Medical," said Jim Chomas, Chief Executive Officer. "Gene's extensive experience in strategic market development brings additional valuable perspective to our Board. I look forward to his contributions as we advance Surefire Medical's growth strategy."

Mr. McGrevin holds an MBA from the University of Pennsylvania's Wharton School. He earned a BA in economics at the University of Pittsburgh.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a platform of innovative infusion systems for the interventional radiology market. Surefire's infusion catheters precisely deliver embolic agents through a novel expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow. The Surefire Infusion System increases embolization efficiency, minimizes reflux and reduces damage to healthy tissue. For more information, please visit www.surefiremedical.com.

SOURCE Surefire Medical, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES